Trials / Completed
CompletedNCT02979054
Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 157 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the performance and safety of T4020 versus saline solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | T4020 | |
| DEVICE | Placebo |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-12-01
- Last updated
- 2019-10-22
- Results posted
- 2019-10-07
Locations
4 sites across 4 countries: Bulgaria, France, Spain, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02979054. Inclusion in this directory is not an endorsement.